CEACAM6 was detected in 65.9% (178/270) of GC specimens with lymph node metastasis, which was higher compared with those without lymph node metastasis (15.7%, 26/166, p=0.000). Here, CEACAM6 is linked to metastatic malignant neoplasm in the lymph nodes.